Ty Hanners appointed Director of Sales, US, focused on OPRA Implant System for Amputees

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA implant system to amputees, announces that Ty Hanners has been appointed Director of Sales, US, focused on expanding the OPRA surgical system product offering to amputees. He will start on October 14, 2024.

Ty Hanners is a results-oriented sales leader with over 20 years in the prosthetic and orthopedic implant industry. He most recently served as a sales leader at Willowood Inc. and has past experience at Össur and Xtremity, innovative prosthetic and medical companies. Ty will be focused on business development, patient capture, and organizational transformation.

"We are thrilled to welcome Ty Hanners to the Integrum team. Ty's leadership and past successes will provide immediate contributions to our expanding products and commercial strategy. Ty is a results-oriented leader with a deep understanding of the industry. He has helped to develop breakthrough healthcare technologies and has experience within the O&P market," comments Jeffrey Zanni, US President, Integrum.

"I'm very impressed by the Integrum portfolio, their approved technologies, and continued innovation in improving life for amputees. I'm excited for this opportunity to manage the US Sales team and drive the success of Integrum," comments Ty Hanners, National Director of Sales, US, Integrum.